Auspex Pharma Raises $12M

Xconomy San Diego — 

Vista, CA-based Auspex Pharmaceuticals has raised $12 million from investors, according to a recent regulatory filing. As I noted when the company arranged a $2 million financing in March, Auspex is developing deuterium-based analogs of clinically validated drugs in multiple therapeutic areas. The deuterium replaces metabolically sensitive hydrogen atoms to create novel therapeutics with “very attractive product profiles.” The investors were not identified, but Auspex previously raised almost $13.9 million in a previous round from Thomas, McNerney & Partners, CMEA Ventures, and Costa Verde Capital.